DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma

DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma

Abstract Background Lung squamous cell carcinoma (LUSC) is prone to metastasis and likely to develop resistance to chemotherapeutic drugs. DNA repair has been reported to be involved in the progression and chemoresistance of LUSC. However, the relationship between LUSC patient prognosis and DNA dama...

Full description

Bibliographic Details
Main Authors: Xinshu Wang, Zhiyuan Huang, Lei Li, Guangxue Wang, Lin Dong, Qinchuan Li, Jian Yuan, Yunhui Li
Format: Article
Language:English
Published: BMC 2022-08-01
Series:BMC Cancer
Subjects:
LUSC
DNA damage repair genes
Risk model
Prognosis
Drug sensitivity
Online Access:https://doi.org/10.1186/s12885-022-09954-x

Internet

https://doi.org/10.1186/s12885-022-09954-x

Similar Items